Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel S Palacios

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Journal of Medicinal Chemistry|October 7, 2022
Drug Hunting at the Nexus of Medicinal Chemistry and Chemical Biology and the Discovery of Novel Therapeutic ModalitiesDaniel S Palacios
RSC Medicinal Chemistry|October 21, 2021
Progress in mechanistically novel treatments for schizophreniaJames Neef, Daniel S Palacios
Proceedings of the National Academy of Sciences of the United States of America|March 4, 2011
Synthesis-enabled functional group deletions reveal key underpinnings of amphotericin B ion channel and antifungal activitiesDaniel S Palacios, Ian Dailey, David M Siebert, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 7, 2012
Amphotericin primarily kills yeast by simply binding ergosterolKaitlyn C Gray, Daniel S Palacios, Ian Dailey, et al.
ACS Medicinal Chemistry Letters|November 22, 2019
Scaffold Morphing Identifies 3-Pyridyl Azetidine Ureas as Inhibitors of Nicotinamide Phosphoribosyltransferase (NAMPT)Daniel S Palacios, Erik L Meredith, Toshio Kawanami, et al.
Bioorganic & Medicinal Chemistry Letters|December 26, 2017
Structure based design of nicotinamide phosphoribosyltransferase (NAMPT) inhibitors from a phenotypic screenDaniel S Palacios, Erik Meredith, Toshio Kawanami, et al.
ACS Medicinal Chemistry Letters|December 20, 2023
Transaminases Provide Key Chiral Building Blocks for the Synthesis of Selective M1/M4 AgonistsChristopher G Thomson, Kelly Boss, Amy Calhoun, et al.
Cell Chemical Biology|July 25, 2020
Systematic Chemogenetic Library AssemblyStephen M Canham, Yuan Wang, Allen Cornett, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Journal of Medicinal Chemistry|October 7, 2022
Drug Hunting at the Nexus of Medicinal Chemistry and Chemical Biology and the Discovery of Novel Therapeutic ModalitiesDaniel S Palacios
RSC Medicinal Chemistry|October 21, 2021
Progress in mechanistically novel treatments for schizophreniaJames Neef, Daniel S Palacios
Proceedings of the National Academy of Sciences of the United States of America|March 4, 2011
Synthesis-enabled functional group deletions reveal key underpinnings of amphotericin B ion channel and antifungal activitiesDaniel S Palacios, Ian Dailey, David M Siebert, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 7, 2012
Amphotericin primarily kills yeast by simply binding ergosterolKaitlyn C Gray, Daniel S Palacios, Ian Dailey, et al.
ACS Medicinal Chemistry Letters|November 22, 2019
Scaffold Morphing Identifies 3-Pyridyl Azetidine Ureas as Inhibitors of Nicotinamide Phosphoribosyltransferase (NAMPT)Daniel S Palacios, Erik L Meredith, Toshio Kawanami, et al.
Bioorganic & Medicinal Chemistry Letters|December 26, 2017
Structure based design of nicotinamide phosphoribosyltransferase (NAMPT) inhibitors from a phenotypic screenDaniel S Palacios, Erik Meredith, Toshio Kawanami, et al.
ACS Medicinal Chemistry Letters|December 20, 2023
Transaminases Provide Key Chiral Building Blocks for the Synthesis of Selective M1/M4 AgonistsChristopher G Thomson, Kelly Boss, Amy Calhoun, et al.
Cell Chemical Biology|July 25, 2020
Systematic Chemogenetic Library AssemblyStephen M Canham, Yuan Wang, Allen Cornett, et al.
Pageof 1